Transforming growth factor beta-1 (TGFB1) and peak bone mass: association between intragenic polymorphisms and quantitative ultrasound of the heel
- PMID: 15955247
- PMCID: PMC1182375
- DOI: 10.1186/1471-2474-6-29
Transforming growth factor beta-1 (TGFB1) and peak bone mass: association between intragenic polymorphisms and quantitative ultrasound of the heel
Abstract
Background: Variance of peak bone mass has a substantial genetic component, as has been shown with twin studies examining quantitative measures such as bone mineral density (BMD) and quantitative ultrasound (QUS). Evidence implicating single nucleotide polymorphisms (SNPs) of the transforming growth factor beta-1 (TGFB1) gene is steadily accumulating. However, a comprehensive look at multiple SNPs at this locus for their association with indices of peak bone mass has not been reported.
Methods: A cohort of 653 healthy Caucasian females 18 to 35 years old was genotyped for seven TGFB1 SNPs. Polymorphisms were detected by restriction endonuclease digestion of amplified DNA segments.
Results: The frequencies of the least common allele at G-800A, C-509T, codon 10 (L10P), codon 25 (R25P), codon 263 (T263I), C861-20T, and 713-8 delC loci were 0.07, 0.33, 0.41, 0.08, 0.04, 0.25 and 0.01, respectively. A significant association was seen between QUS Stiffness Index (QUS-SI) and the SNP at codon 10 and the linked promoter SNP, C-509T. This association remained significant after multiple regression was used to incorporate important clinical covariates--age, BMI, level of activity, family history, and caffeine intake--into the model.
Conclusion: The association of QUS-SI with -509T is consistent with a gene-dose effect, while only individuals homozygous for the codon 10P allele showed a significant increase. In this cohort of young healthy Caucasian females, the T allele at position -509 is associated with greater bone mass as measured by calcaneal ultrasound.
Figures


Similar articles
-
Large-scale population-based study shows no association between common polymorphisms of the TGFB1 gene and BMD in women.J Bone Miner Res. 2007 Feb;22(2):195-202. doi: 10.1359/jbmr.061016. J Bone Miner Res. 2007. PMID: 17059371
-
Alleles of the estrogen receptor alpha-gene and an estrogen receptor cotranscriptional activator gene, amplified in breast cancer-1 (AIB1), are associated with quantitative calcaneal ultrasound.J Bone Miner Res. 2000 Nov;15(11):2231-9. doi: 10.1359/jbmr.2000.15.11.2231. J Bone Miner Res. 2000. PMID: 11092404
-
Oestrogen receptor alpha genotype, and interactions between vitamin D receptor and transforming growth factor-beta1 genotypes are associated with quantitative calcaneal ultrasound in postmenopausal women.Clin Endocrinol (Oxf). 2004 Feb;60(2):232-40. doi: 10.1046/j.1365-2265.2003.01972.x. Clin Endocrinol (Oxf). 2004. PMID: 14725686
-
A Cross-Sectional Study of the Association of VDR Gene, Calcium Intake, and Heel Ultrasound Measures in Early Adulthood.Calcif Tissue Int. 2016 Mar;98(3):226-34. doi: 10.1007/s00223-015-0086-2. Epub 2015 Nov 21. Calcif Tissue Int. 2016. PMID: 26590811
-
[Association of polymorphisms of the transforming growth factor-beta 1 gene with genetic susceptibility to osteoporosis].Rinsho Byori. 2001 Sep;49(9):900-5. Rinsho Byori. 2001. PMID: 11685778 Review. Japanese.
Cited by
-
COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women.Osteoporos Int. 2007 Feb;18(2):235-43. doi: 10.1007/s00198-006-0225-8. Epub 2006 Oct 5. Osteoporos Int. 2007. PMID: 17021946
-
Inkjet-based biopatterning of SDF-1β augments BMP-2-induced repair of critical size calvarial bone defects in mice.Bone. 2014 Oct;67:95-103. doi: 10.1016/j.bone.2014.07.007. Epub 2014 Jul 10. Bone. 2014. PMID: 25016095 Free PMC article.
-
Association of TGFB1 29C/T and IL6 -572G/C polymorphisms with developmental hip dysplasia: a case-control study in adults with severe osteoarthritis.Int Orthop. 2015 Apr;39(4):793-8. doi: 10.1007/s00264-015-2675-0. Epub 2015 Jan 22. Int Orthop. 2015. PMID: 25603974
-
Association of TGF-β1 and IL-10 Gene Polymorphisms with Osteoporosis in a Study of Taiwanese Osteoporotic Patients.Genes (Basel). 2021 Jun 18;12(6):930. doi: 10.3390/genes12060930. Genes (Basel). 2021. PMID: 34207210 Free PMC article.
-
Significant Improvement of Clinical Symptoms, Bone Lesions, and Bone Turnover after Long-Term Zoledronic Acid Treatment in Patients with a Severe Form of Camurati-Engelmann Disease.Mol Syndromol. 2017 Nov;8(6):294-302. doi: 10.1159/000479859. Epub 2017 Sep 9. Mol Syndromol. 2017. PMID: 29230158 Free PMC article.
References
-
- Patel MS, Rubin LA, Cole DE. Genetic determinants of peak bone mass. In: Henderson JE, Goltzman D, editor. The Osteoporosis Primer. Cambridge: Cambridge University Press; 2000. pp. 131–146.
-
- Rubin LA, Hawker GA, Peltekova VD, Fielding LJ, Ridout R, Cole DE. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res. 1999;14:633–643. - PubMed
-
- Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res. 1996;11:306–311. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous